Creating effective new age communications programs for pharmaceutical manufacturers, healthcare provider organizations and health care insurers requires focus and expertise on:

• controlling costs while ensuring communications effectiveness

• managing to compliance - from marketing content through mandated content and timelines

• undertsanding the critical role of data to ensuring accurate and effective communications

• recognizing the evolving importance of online media, social media tools and the empowered patient/consumer

In total...it takes new thinking, new skills and new commitment to execution in a unique marketplace.

Cierant has created a dedicated practice focused on the unique challenges of this marketplace --- helping clients to overcome the challenges of communication in the healthcare market while taking advantage of the opportunities afforded by new digital printing technologies, online application capabilities and cross-media measurement tools.

Cierant's Health Practice leverages our core competency in data analysis, management and utilization, software applications development and integration, and cross-media marketing creative strategy and implemention, to drive programs such as:

• innovative non-personal communications programs to healthcare providers who are less and less accessible to traditional detail reps

• advanced strategies for geotargeted, healthplan-specific, cross-media marketing marketing programs

• cost-effective online customization tools for production of regionalized/localized marketing materials such as pharma formulary status sell sheets or commercial summary of benefits documents

• cost-effective, flexible, on-demand layout of healthcare provider directories, formularies or other long-form, data-driven documents

The Cierant team understands the sensitive nature of data in the healthcare arena and has worked to build project management processes, software applications and program execution strategies that ensure secure and effective programs while also keeping an eye on costs in a market increasingly challenged by regulatory oversight and continues rule changes.